BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu B, Wang J, Wang X, Zhu M, Chen F, Shen Y, Zhong Z. CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer. Oncol Lett 2020;20:257. [PMID: 32994820 DOI: 10.3892/ol.2020.12120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang ZZ, Li XT, Li QJ, Zhou JX. Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression. Dig Dis Sci 2022. [PMID: 35650416 DOI: 10.1007/s10620-022-07529-1] [Reference Citation Analysis]
2 Huang J, Chen Z, Ding C, Lin S, Wan D, Ren K. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Front Oncol 2021;11:711402. [PMID: 34497764 DOI: 10.3389/fonc.2021.711402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]